z-logo
open-access-imgOpen Access
Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4 + T Cell Responses
Author(s) -
Eun-Ha Kim,
Quyen Thi Nguyen,
Mark Anthony B. Casel,
Rare Rollon,
SeMi Kim,
YoungIl Kim,
Kwang-Min Yu,
SeungGyu Jang,
Jihyun Yang,
Haryoung Poo,
Jae U. Jung,
Young Ki Choi
Publication year - 2022
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.01873-21
Subject(s) - virology , coinfection , biology , antibody , virus , neutralizing antibody , covid-19 , influenza a virus , orthomyxoviridae , betacoronavirus , immunology , disease , infectious disease (medical specialty) , outbreak , medicine
The cocirculation of influenza virus merging with the COVID-19 pandemic raises a potentially severe threat to public health. Recently, increasing numbers of SARS-CoV-2 and influenza virus coinfection have been reported from many countries.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom